LICENSE AGREEMENTS WITH UMASS |
9 Months Ended |
|---|---|
Sep. 30, 2025 | |
| Goodwill and Intangible Assets Disclosure [Abstract] | |
| LICENSE AGREEMENTS WITH UMASS |
NOTE 12 – LICENSE AGREEMENTS WITH UMASS
On June 26, 2025, Tonix obtained an exclusive worldwide license from UMass Chan Medical School for the development of TNX-4800 (formerly known as mAb 2217LS). As of September 30, 2025, other than the upfront fee of $1.3 million, no payments have been accrued or paid in relation to this agreement.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for all or part of the information related to intangible assets. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|